Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-22

Clinical Trial Update: Exploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab® (Abciximab) in Acute MI Patients [Phase 2]

View source ↗

Summary

This document describes an ongoing Phase 2 exploratory trial evaluating the efficacy and safety of Clotinab (Abciximab) in patients with acute myocardial infarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotinab

Snippet

Sponsor: ISU Abxis Co., Ltd. | Conditions: Acute Myocardial Infarction | Phase 2 | Status: UNKNOWN